000040715 000__ 01432cam\a2200805\i\4500
000040715 001__ 40715
000040715 003__ SzGeWIPO
000040715 005__ 20230630124658.0
000040715 008__ 200401s2014\\\\gw\a\\\\ob\\\\000\0\eng\d
000040715 020__ $$a9783845251288$$qe-book
000040715 035__ $$a(MiAaPQ)EBC4830532
000040715 035__ $$a(Au-PeEL)EBL4830532
000040715 035__ $$a(CaPaEBR)ebr11366866
000040715 035__ $$a(OCoLC)980702303
000040715 035__ $$a(wipo)EBC4830532
000040715 040__ $$aMiAaPQ$$beng$$erda$$cMiAaPQ
000040715 041__ $$aeng
000040715 08204 $$a616.394
000040715 1001_ $$aDonghi, Monica,$$eauthor.
000040715 24510 $$aPatent Strategy in Pharmaceutical Industry : Are additional patents valuable? /$$cMonica Donghi, author.
000040715 264_1 $$aBaden-Baden, Germany :$$bNomos Verlagsgesellschaft,$$c2014.
000040715 264_4 $$c©2014
000040715 300__ $$a1 online resource (85 pages) :$$billustrations
000040715 336__ $$atext$$2rdacontent
000040715 337__ $$acomputer$$2rdamedia
000040715 338__ $$aonline resource$$bcr$$2rdacarrier
000040715 4901_ $$aMunich Intellectual Property Law Center - MIPLC
000040715 520__ $$aThis thesis is the result of research and analysis of the patent portfolio regarding two commercially successful drugs of significant importance for public health. The investigation has sought to analyse the various motivations which are behind such patent portfolio as well as its potential value.
000040715 650_0 $$aDrugs$$xPatents
000040715 650_0 $$aMedicine
000040715 650_0 $$aPharmaceutical industry
000040715 650_0 $$aLaw$$xGeneral
000040715 655_4 $$aElectronic books
000040715 7102_ $$aNomos Verlagsgesellschaft
000040715 7972_ $$aProQuest (Firm)
000040715 830__ $$aMunich Intellectual Property Law Center - MIPLC$$vno. 20
000040715 85640 $$uhttps://ebookcentral.proquest.com/lib/wipo/detail.action?docID=1645181$$zView this Ebook
000040715 904__ $$aBook
000040715 942__ $$2ddc$$cEBOOK
000040715 980__ $$aBIB
000040715 980__ $$aOS